2024 asa guidance glp-1 receptor agonists perioperative AHA/ACC/ACS/ASNC/HRS/SCA/SCCT/SCMR/SVM Guideline for Cardiovascular Management for Noncardiac Surgery: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines Glucagon-Like Peptide-1 Receptor Agonists in

Background Bariatric surgery (BS) is the most effective treatment for severe obesity, but a significant proportion of patients experience insufficient weight loss (IWL) or weight regain

In clinical trials, people using GLP-1 drugs lost an average of about 10 pounds more than people using a placebo

Find out if GLP-1 drugs is covered by Humana, typical copay ranges, prior-auth rules, and affordable alternatives

An AI study analyzing more than 400,000 Reddit posts identified patient-reported symptoms associated with GLP-1 medications that do not appear on drug labels.

Are you a candidate?

Given its multi-target efficacy and botanical safety profile, BBR represents a cost-effective adjuvant for obesity management, particularly in resource-limited settings